Literature DB >> 22082659

Promoter variants determine γ-aminobutyric acid homeostasis-related gene transcription in human epileptic hippocampi.

Katharina Pernhorst1, Anna Raabe, Pitt Niehusmann, Karen M J van Loo, Alexander Grote, Per Hoffmann, Sven Cichon, Thomas Sander, Susanne Schoch, Albert J Becker.   

Abstract

The functional consequences of single nucleotide polymorphisms associated with episodic brain disorders such as epilepsy and depression are unclear. Allelic associations with generalized epilepsies have been reported for single nucleotide polymorphisms rs1883415 (ALDH5A1; succinic semialdehyde dehydrogenase) and rs4906902 (GABRB3; GABAA β3), both of which are present in the 5' regulatory region of genes involved in γ-aminobutyric acid (GABA) homeostasis. To address their allelic association with episodic brain disorders and allele-specific impact on the transcriptional regulation of these genes in human brain tissue, DNA and messenger RNA (mRNA) isolated from hippocampi were obtained at epilepsy surgery of 146 pharmacoresistant mesial temporal lobe epilepsy (mTLE) patients and from 651 healthy controls. We found that the C allele of rs1883415 is accumulated to a greater extentin mTLE versus controls. By real-time quantitative reverse transcription-polymerase chain reaction analyses, individuals homozygous for the C allele showed higher ALDH5A1 mRNA expression. The rs4906902 G allele of the GABRB3 gene was overrepresented in mTLE patients with depression; individuals homozygous for the G allele showed reduced GABRB3 mRNA expression. Bioinformatic analyses suggest that rs1883415 and rs4906902 alter the DNA binding affinity of the transcription factors Egr-3 in ALDH5A1 and MEF-2 in GABRB3 promoters, respectively. Using in vitro luciferase transfection assays, we observed that, in both cases, the transcription factors regulate gene expression depending on the allelic variant in the same direction as in the human hippocampi. Our data suggest that distinct promoter variants may sensitize individuals for differential, potentially stimulus-induced alterations of GABA homeostasis-relevant gene expression. This might contribute to the episodic onset of symptoms and point to new targets for pharmacotherapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22082659     DOI: 10.1097/NEN.0b013e318238b9af

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder.

Authors:  Laura M Hodges; Abby J Fyer; Myrna M Weissman; Mark W Logue; Fatemeh Haghighi; Oleg Evgrafov; Allessandro Rotondo; James A Knowles; Steven P Hamilton
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

2.  CASK stabilizes neurexin and links it to liprin-α in a neuronal activity-dependent manner.

Authors:  Leslie E W LaConte; Vrushali Chavan; Chen Liang; Jeffery Willis; Eva-Maria Schönhense; Susanne Schoch; Konark Mukherjee
Journal:  Cell Mol Life Sci       Date:  2016-03-25       Impact factor: 9.261

Review 3.  Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.

Authors:  P Malaspina; J-B Roullet; P L Pearl; G R Ainslie; K R Vogel; K M Gibson
Journal:  Neurochem Int       Date:  2016-06-14       Impact factor: 3.921

4.  Identification of a sex-stratified genetic algorithm for opioid addiction risk.

Authors:  David Bright; Anna Langerveld; Susan DeVuyst-Miller; Claire Saadeh; Ashley Choker; Elisabeth Lehigh; Stephanie Wheeler; Ahed Zayzafoon; Minji Sohn
Journal:  Pharmacogenomics J       Date:  2021-02-15       Impact factor: 3.550

5.  SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility.

Authors:  Katri Silvennoinen; Kinga Gawel; Despina Tsortouktzidis; Albert J Becker; Camila V Esguerra; Sanjay M Sisodiya; Julika Pitsch; Saud Alhusaini; Karen M J van Loo; Richard Picardo; Zuzanna Michalak; Susanna Pagni; Helena Martins Custodio; James Mills; Christopher D Whelan; Greig I de Zubicaray; Katie L McMahon; Wietske van der Ent; Karolina J Kirstein-Smardzewska; Ettore Tiraboschi; Jonathan M Mudge; Adam Frankish; Maria Thom; Margaret J Wright; Paul M Thompson; Susanne Schoch
Journal:  Acta Neuropathol       Date:  2022-05-12       Impact factor: 15.887

6.  The transcription factor NRSF contributes to epileptogenesis by selective repression of a subset of target genes.

Authors:  Shawn McClelland; Gary P Brennan; Celine Dubé; Seeta Rajpara; Shruti Iyer; Cristina Richichi; Christophe Bernard; Tallie Z Baram
Journal:  Elife       Date:  2014-08-12       Impact factor: 8.140

Review 7.  Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment.

Authors:  Sarita Thakran; Debleena Guin; Pooja Singh; Priyanka Singh; Samiksha Kukal; Chitra Rawat; Saroj Yadav; Suman S Kushwaha; Achal K Srivastava; Yasha Hasija; Luciano Saso; Srinivasan Ramachandran; Ritushree Kukreti
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.